With the analysis among 5,122 patents, we discovered top 288 key players by total patent application. Genentech, Inc., ImmunoGen, Inc., Immunomedics, Inc. are dominant in this area. They take 31.47% of the total patent filing.
California, United States
Patent: 858
Massachusetts, United States
Patent: 509
New Jersey, United States
Patent: 245
New York, United States
Patent: 202
F. Hoffmann-La Roche Ltd.
ZURICH, Switzerland
Patent: 154
New Jersey, United States
Patent: 126
Bolt Biotherapeutics, Inc.
California, United States
Patent: 124
Basel-Stadt, Switzerland
Patent: 100
With the analysis among 123 patents, we discovered top 11 start-ups by total patent application. Hangzhou Sumgen Biotech Co., Ltd., Biosion, Inc., Oblique Therapeutics AB are active in this area.
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 35
Jiangsu Sheng, China
Patent: 31
Institut National de la Santé et de la Recherche Médicale
Fortis Therapeutics, Inc.
California, United States
Patent: 10
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 4
Suzhou SmartNuclide Biopharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 1
Oncxerna Therapeutics, Inc.
Massachusetts, United States
Patent: 1
OncoOne Research & Development GmbH
Niederösterreich, Austria
Patent: 1
Washington, United States
Patent: 1
With the analysis among related 1,535 patents applied in the last 5 years. We discover 164 most active companies in this area. The fast-growing Genentech, Inc., F. Hoffmann-La Roche Ltd., ImmunoGen, Inc. take 23.78% of patent filing during this period.
California, United States
Patent: 126
F. Hoffmann-La Roche Ltd.
Massachusetts, United States
Patent: 119
Bolt Biotherapeutics, Inc.
California, United States
Patent: 109
California, United States
Patent: 60
New York, United States
Patent: 58
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 53
Fusion Pharmaceuticals, Inc.
Ontario, Canada
Patent: 44
Illinois, United States
Patent: 38
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 35
With the analysis among related 1,535 patents in last 5 years, we discover 100 new entrants. Innovent Biologics (Suzhou) Co. Ltd., Fusion Pharmaceuticals, Inc., Hangzhou Sumgen Biotech Co., Ltd. are the most active new entrants in this area.
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 53
Fusion Pharmaceuticals, Inc.
Ontario, Canada
Patent: 44
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 35
Jiangsu Sheng, China
Patent: 31
Beijing Mabworks Biotech Co., Ltd.
Beijing Shi, China
Patent: 27
Sumgen Monoclonal Antibody (Beijing) Biotechnology Co Ltd
Beijing Shi, China
Patent: 27
California, United States
Patent: 25
Shanghai Jibei Biotechnology Co., Ltd.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 15
With the analysis among 502 patents, we discovered top 48 universities and scientific research institutions by total patent application. The Scripps Research Institute, University of Minnesota, Yale University are dominant in this area. They take 38.05% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 41
Minnesota, United States
Patent: 22
Connecticut, United States
Patent: 16
Georgetown University School of Medicine
District of Columbia, United States
Patent: 15
Tennessee, United States
Patent: 14
Rutgers State University of New Jersey
New Mexico, United States
Patent: 13
University of Southern California
California, United States
Patent: 9
New York, United States
Patent: 7
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 6